ASF & PARTNERS
ALPORT SYNDROME RESEARCH FUNDING PROGRAM
2019 REQUEST FOR LETTERS OF INTENT
The principal goal of the Alport Syndrome Foundation, Inc. (ASF) & Partners is to find novel treatments to prevent kidney failure and hearing loss in all patients with Alport syndrome.
Application Focus and Funding
Please note that there are two separate categories of funding for this competition:
1. Identification and investigation of target pathways in disease progression and/or Development of means to improve early-stage, definitive, and predictive diagnosis.
Funding: It is anticipated that two research projects will be selected in this category, totaling US $125,000 each, over a one- to two-year timeframe.
2. Repurposing of an FDA-approved drug to improve the current standard of care.
Funding: It is anticipated that one project will be selected in this category, totaling US $100,000, over a one-year timeframe.
Early stage investigators are encouraged to apply. There are no geographical limitations of this funding.
Please clearly identify which of the two categories you are applying for. Letters of intent (LoIs) will be evaluated by an independent peer review process. LoIs should be no longer than 2 pages in length and must be in accordance with the instructions detailed in the ASF & Partners Alport Syndrome Research Funding Program here. Authors of the LoIs found to have the best merit for funding will be invited to submit a full proposal application 10–15 pages in length for further independent peer review. Final grant recipients will be selected from this pool and notified in June 2019. The detailed schedule can be found here.
The deadline for submission of an LoI is Friday, February 8, 2019 by 7:00 pm Massachusetts Time/EST (no late submittals will be accepted).
For Additional Information, go to www.alportsyndrome.org or Contact:
André Weinstock, PhD, Research Committee Chair,
Alport Syndrome Foundation, Inc.